257 related articles for article (PubMed ID: 31752626)
1. The Progressive Supranuclear Palsy: Past and Present Aspects.
Parthimos TP; Schulpis KH
Clin Gerontol; 2020; 43(2):155-180. PubMed ID: 31752626
[No Abstract] [Full Text] [Related]
2. Effects of anodal transcranial direct current stimulation on cognitive dysfunction in patients with progressive supranuclear palsy.
Alexoudi A; Patrikelis P; Deftereos S; Fasilis T; Karakalos D; Verentzioti A; Korfias S; Sakas D; Gatzonis S
Psychiatriki; 2019; 30(4):320-328. PubMed ID: 32283535
[TBL] [Abstract][Full Text] [Related]
3. Pathomechanisms of cognitive impairment in progressive supranuclear palsy.
Jellinger KA
J Neural Transm (Vienna); 2023 Apr; 130(4):481-493. PubMed ID: 36862189
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Ali F; Josephs K
Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
[TBL] [Abstract][Full Text] [Related]
5. [A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy].
Yoshiike T; Ueda S; Takahashi M; Suda K; Furuta K; Koyama K
Seishin Shinkeigaku Zasshi; 2014; 116(5):359-69. PubMed ID: 24992742
[TBL] [Abstract][Full Text] [Related]
6. Progressive supranuclear palsy.
Giagkou N; Höglinger GU; Stamelou M
Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
[TBL] [Abstract][Full Text] [Related]
9. The phenotypic spectrum of progressive supranuclear palsy.
Respondek G; Höglinger GU
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S34-6. PubMed ID: 26421392
[TBL] [Abstract][Full Text] [Related]
10. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
11. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.
Burrell JR; Hodges JR; Rowe JB
Mov Disord; 2014 Apr; 29(5):684-93. PubMed ID: 24757116
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
Painous C; Martí MJ; Simonet C; Garrido A; Valldeoriola F; Muñoz E; Cámara A; Compta Y
Parkinsonism Relat Disord; 2020 May; 74():67-73. PubMed ID: 32536421
[TBL] [Abstract][Full Text] [Related]
13. Rate of decline in progressive supranuclear palsy.
Litvan I; Kong M
Mov Disord; 2014 Apr; 29(4):463-8. PubMed ID: 24615741
[TBL] [Abstract][Full Text] [Related]
14. Progressive Supranuclear Palsy: Neuropsychopathological, Therapeutical and Bioethical Aspects.
Vecchio I; Tornali C; Malaguarnera G; Bragazzi NL; Malaguarnera M
Curr Alzheimer Res; 2018; 15(10):959-963. PubMed ID: 29732973
[TBL] [Abstract][Full Text] [Related]
15. A case of atypical progressive supranuclear palsy.
Spaccavento S; Del Prete M; Craca A; Loverre A
Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
[TBL] [Abstract][Full Text] [Related]
16. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
Rippon GA; Boeve BF; Parisi JE; Dickson DW; Ivnik RI; Jack CR; Hutton M; Baker M; Josephs KA; Knopman DS; Petersen RC
Neurocase; 2005 Jun; 11(3):204-11. PubMed ID: 16006341
[TBL] [Abstract][Full Text] [Related]
17. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
Sitek EJ; Konkel A; Dąbrowska M; Sławek J
Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
[TBL] [Abstract][Full Text] [Related]
18. Progressive supranuclear palsy: where are we now?
Burn DJ; Lees AJ
Lancet Neurol; 2002 Oct; 1(6):359-69. PubMed ID: 12849397
[TBL] [Abstract][Full Text] [Related]
19. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
Rezvanian S; Litvan I; Standaert D; Jankovic J; Reich SG; Hall D; Shprecher DR; Bordelon Y; Dubinsky R; Kluger B
Parkinsonism Relat Disord; 2020 Sep; 78():56-60. PubMed ID: 32731191
[TBL] [Abstract][Full Text] [Related]
20. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
